These POC robots operate using Clotild wires, navigating and sensing tissues in the hands of Robocath’s R-One commercial robotic system (and next-generation robots under development), with animal thrombi implanted in the models to simulate strokes.
Despite the heavy disease burden imposed on patients by lower limb amputations, related online patient education…
On March 17, 2026, Sensome and Robocath of France jointly completed the world’s first proof-of-concept trial of intracranial thrombectomy using a combination of intelligent thrombus-sensing guidewire and vascular interventional robot.
TACE combined with tislelizumab and lenvatinib can bring significant clinical benefits.
Clotild is the world’s first thrombosis-sensing neurovascular guidewire developed by Sensome. Its core innovation lies in integrating micro-biosensors and machine learning algorithms into a standard interventional guidewire, providing real-time histological information for endovascular treatment of acute ischemic stroke (AIS) and peripheral artery disease (PAD).
Starlight Cardiovascular Announces First Baby inthe World Treated withLifeline Stent System atCincinnati Children’sHospital
Pulmonary embolism
Vascular intervention
Tumor intervention
NuPulseCV is a medical device company specializing in the treatment of heart failure. Its core product is the iVAS, now branded as NuPulse Voyage.
